Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
批准号:
RGPIN-2017-06461
负责人:
Rudd, Christopher
金额:
$2.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of our NSERC research program is to understand the antigen-receptor proximal signaling events that control downstream functions such as calcium mobilization and the aggregation of adaptors and kinases. The initial events that mediate activation of T-cells are mediated by proximal tyrosine kinases such as p56lck and ZAP-70 and their phosphorylation of adaptor proteins. Adaptors in turn mediate the formation of complexes needed to integrate signalling in cells. One key adaptor protein is SLP-76 (SH2 domain containing leukocyte protein of 76kDa) which plays a positive role in promoting T cell activation and development. SLP-76 contains a sterile alpha motif (SAM) domain that we previously showed mediates SLP-76 dimer and oligomer formation. We have also shown that the tyrosine kinase ACK1 Cdc42 (cell division cycle 42)-activated tyrosine kinase 1 (ACK1 or Tnk2) binds to SLP-76 and that the loss of the SLP-76 SAM domain disrupts binding. The classic model for TCR induction of phospholipase C (PLCγ1) activation and calcium mobilization involves another kinase ZAP-70 and its phosphorylation and its recruitment of interleukin-2-inducible T-cell kinase (ITK) to SLP-76. We found that ACK1 expression induced SLP-76 phosphorylation and calcium influx, and as such, the SLP-76-ACK1 module could represent a second modular pathway for the activation calcium mobilization and F-actin assembly in T-cells. To test this model, we propose: Aim 1: to examine whether the SAM domain mediated oligomerization is needed for the binding of ACK1 to SLP-76. We have discovered that ACK1 can phosphorylate SLP-76 on these key tyrosines and binds to SLP-76 via its SAM domain. This introduces are novel mechanism to regulate SLP-76 function in T-cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$4.95万
-
财政年份:2021
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2020
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2019
-
负责人:Rudd, Christopher
-
依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
-
批准号:RGPIN-2017-06461
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.48万
-
财政年份:2018
-
负责人:Rudd, Christopher
-
依托单位:
国内基金
海外基金
登录
查看更多内容
选择性ACK1抑制剂的设计、合成及抗肿瘤活性研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭靖
-
依托单位:
ACK1/TNK2在嗜神经肠道病毒感染扩散中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:蒋红兵
-
依托单位:
Lnc-MPLKIP-6竞争性抑制SIAH1介导的ACK1泛素化调控肺腺癌EGFR-TKI耐药的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:马建群
-
依托单位:
Ack1介导新型EGFR三代抑制剂120067耐药机制研究
-
批准号:81903638
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:张弢
-
依托单位:
DDR2在炎症信号通路IL-6/STAT3/ACK1介导肝癌发生中的作用及机制
-
批准号:81760496
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:谢斌辉
-
依托单位:
非受体酪氨酸激酶ACK1通过调控YAP蛋白活性促进膀胱癌生长的机制研究
-
批准号:81602223
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:胡连鑫
-
依托单位:
ACK1介导的受体酪氨酸激酶信号在肿瘤发生发展中的作用
-
批准号:81472558
-
项目类别:面上项目
-
资助金额:74.0万元
-
批准年份:2014
-
负责人:杨万年
-
依托单位:
Ack1介导的PDGFR-AKT信号在神经胶质瘤发生发展中的功能及相关机制研究
-
批准号:81372705
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:葛建伟
-
依托单位:
ACK1作为新的心肌肥厚和心力衰竭治疗靶点的实验研究
-
批准号:30900590
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2009
-
负责人:陈莉
-
依托单位: